Journey Medical Revenue and Competitors
Estimated Revenue & Valuation
- Journey Medical's estimated annual revenue is currently $29.1M per year.
- Journey Medical's estimated revenue per employee is $201,000
Employee Data
- Journey Medical has 145 Employees.
- Journey Medical grew their employee count by 48% last year.
Journey Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $22.3M | 111 | 8% | N/A | N/A |
#2 | $17.7M | 88 | -19% | N/A | N/A |
#3 | $6.6M | 33 | -8% | N/A | N/A |
#4 | $29.1M | 145 | 48% | N/A | N/A |
#5 | $1.2M | 6 | -50% | N/A | N/A |
#6 | $2.2M | 11 | 10% | N/A | N/A |
#7 | $4.8M | 24 | -17% | N/A | N/A |
#8 | $34.8M | 173 | 5% | N/A | N/A |
#9 | $46.2M | 230 | 5% | N/A | N/A |
#10 | $3.2M | 16 | -11% | N/A | N/A |
What Is Journey Medical?
Journey Medical Corporation (Journey) is an innovative company focused on developing, acquiring, licensing, and commercializing branded dermatology products.\n\nJourney’s team is comprised of industry experts with decades of experience commercializing some of the most successful dermatology products in the prescription pharmaceutical industry. Journey is a subsidiary of Fortress Biotech, Inc.
keywords:N/A
N/A
Total Funding
145
Number of Employees
$29.1M
Revenue (est)
48%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Journey Medical News
The Wayne State University School of Medicine Class of 2024 started its medical education journey solely online, inspiring an innovative...
Improving the quality of healthcare while lowering costs and increasing access in rural Pennsylvania counties is challenging, she said.
Dr. Fabbro sits down with Journey Medical to discuss cutaneous T-cell lymphoma, including what it is, why it occurs and how those affected can...
Other Companies in Scottsdale
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $40.5M | 145 | 9% | N/A |
#2 | $27.9M | 146 | 7% | N/A |
#3 | $46.9M | 147 | -2% | N/A |
#4 | $46.9M | 147 | -12% | N/A |
#5 | $23.9M | 150 | 39% | N/A |